Related Experiment Video
Updated: Nov 23, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA 452 regulates ASB8, NOL8, and CDR2 expression in colorectal cancer cells
Ji-Su Mo1,2, Soo-Cheon Chae3,4
1Department of Pathology, School of Medicine, Wonkwang University, Iksan, Chonbuk, 54538, Republic of Korea.
Background:
MicroRNAs play important roles in the pathogenesis of human diseases by regulating target gene expression in specific cells or tissues. Previously, we identified microRNA 452 (MIR452), which was specifically up-regulated in early stage human colorectal cancer (CRC) tissue.
Objective:
The current study aims to identify and verify the target genes of MIR452 associated with CRC.
Methods:
A luciferase reporter system was used to confirm the effect of MIR452 on ASB8, NOL8, and CDR2 expression. The expression levels of MIR452 and the target genes were evaluated by quantitative RT-PCR (qRT-PCR) and western blotting.
Results:
We verified the association between MIR452 and three genes, ASB8, NOL8, and CDR2, and showed that their transcripts were down-regulated by MIR452. Up-regulated MIR452 also down-regulated ASB8, NOL8, and CDR2 mRNA and protein levels in CRC cells. CDR2 protein expression was decreased in CRC tissues compared to adjacent non-tumor tissues.
Conclusions:
These results suggest that ASB8, NOL8, and CDR2 were target genes of MIR452 in CRC cells and that up-regulated MIR452 in CRC tissue regulated ASB8, NOL8, and CDR2 expression during colorectal carcinogenesis.
Insights
MicroRNA 452 (MIR452) targets ASB8, NOL8, and CDR2 in colorectal cancer (CRC). Upregulated MIR452 in CRC downregulates these genes, suggesting their role in colorectal carcinogenesis.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs are crucial in disease pathogenesis by regulating gene expression.
- MicroRNA 452 (MIR452) is upregulated in early-stage human colorectal cancer (CRC).
Purpose of the Study:
- To identify and validate MIR452 target genes implicated in CRC.
- To investigate the regulatory role of MIR452 in colorectal carcinogenesis.
Main Methods:
- Utilized a luciferase reporter system to confirm MIR452's effect on ASB8, NOL8, and CDR2.
- Employed quantitative RT-PCR (qRT-PCR) and western blotting to assess gene and protein expression levels.
Main Results:
- Confirmed MIR452 directly targets ASB8, NOL8, and CDR2.
- Demonstrated that upregulated MIR452 downregulates ASB8, NOL8, and CDR2 mRNA and protein in CRC cells.
- Observed decreased CDR2 protein expression in CRC tissues compared to non-tumor tissues.
Conclusions:
- ASB8, NOL8, and CDR2 are validated target genes of MIR452 in CRC.
- Upregulated MIR452 contributes to colorectal carcinogenesis by regulating ASB8, NOL8, and CDR2 expression.
More Related Videos
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...